Malaria is a global health problem, where millions of people are being affected. It is a well-known fact that artemisinin is the only effective anti-malarial drug which is produced from the Chinese medicinal plant Artemisia annua. Currently, the prevailing issue is that the cultivation of Artemisia annua leaves cannot meet the global demand.
In response to this challenge, an innovative new warning implant system has been developed to detect four common cancers (lung, prostate, breast and colon). The level of calcium in a person’s blood would constantly be checked and if the calcium levels are too high, it warns the patient about the cancer onset by growing an artificial mole on the person’s skin.
The brain is the most difficult part of the body to assess especially the level of signaling molecules called cytokines. Cytokines are secreted by glial cells, which could make up nearly 90% of all brain cells. Cytokines play a key role in controlling moods, cognition and behavior, which directly influences mental health.
Probiotics are defined as beneficial bacteria that are consumed to boost the populations of more beneficial microbes. The importance of probiotics in health improvement seems to be growing worldwide with more awareness of the benefits. For this reason, numerous research works are currently being conducted in the field of probiotics.
The continuing increase in life expectancy, as one of the most important factors of development in societies, indicates the increasing focus on health and its ever booming market, with an estimated average return rate of 18 percent.
Sweden-based Telehealth startup Kry has raised $66 million series B funding round led by Index Ventures, with participation from existing investors Creandum, Accel, and Project A. Just a year ago the company raised its venture capital funding of $22.8 Million
San Francisco based Healthcare venture capital firm Alta Partners has launched funds titled as Alta Partner NextGen Fund I. The new fund will focus on the new development of therapeutics and health technology services. This will be the 9th fund in Alta Partners firms History.
Healthcare industry stakeholders say the FDA should consider a type of measuring stick when evaluating a vendor’s cybersecurity culture to decide whether it meets the requirements for the agency’s proposed fast-past program for premarket approval of "software as a medical device" products (SaMD). Until the end of the last month, the FDA accepted proposals on its working model for a SaMD pre-approval program
Capsule-type micro-robots that can enclose cells and drugs for delivering to specified parts of the human body have been developed by an international team of researchers, led by the Director of DGIST-ETH Micro-robot Research Center, professor Hongsoo Choi. The lids of these micro-robots have been tailor-made to be opened and closed, unlike standard methods which have been positioned to install cells or drugs outside of micro-robots.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.